Back to GetFilings.com



Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

FORM 10-Q

 

(Mark One)

 

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended: March 31, 2004

 

OR

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from              to             

 

Commission file number: 000-49842

 


 

CEVA, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   77-0556376
(State or Other Jurisdiction of Incorporation or Organization)   (I.R.S. Employer Identification No.)
2033 Gateway Place, Suite 150, San Jose, California   95110-1002
(Address of Principal Executive Offices)   (Zip Code)

 

(408) 514-2900

(Registrant’s Telephone Number, Including Area Code)

 


 

Indicate by check mark whether the registrant: (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date: 18,376,773 shares of common stock, $0.001 par value, as of May 5, 2004.

 


 


Table of Contents

TABLE OF CONTENTS

 

    

Page


PART I.   FINANCIAL INFORMATION

    

Item  1.    Financial Statements (Unaudited)

  

4

                Interim Condensed Consolidated Balance Sheets at March 31, 2004 and December 31, 2003

  

4

                Interim Condensed Consolidated Statements of Operations for the three months ended March 31, 2004 and 2003.

  

5

                Interim Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2004 and 2003

  

6

                Interim Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2004 and 2003

  

7

                Notes to the Interim Condensed Consolidated Financial Statements

  

8

Item  2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

12

Item  3.    Quantitative and Qualitative Disclosures About Market Risk

  

24

Item  4.    Controls and Procedures

  

25

PART II. OTHER INFORMATION

    

Item  6.    Exhibits and Reports on Form 8-K

  

26

SIGNATURES

  

27

CERTIFICATIONS

    

 

2


Table of Contents

FORWARD-LOOKING STATEMENTS

 

This quarterly report includes forward-looking statements that are subject to a number of risks and uncertainties. All statements, other than statements of historical facts, included in this quarterly report regarding our strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans, and objectives of management are forward-looking statements. The words “will”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “project”, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements in this report contain these identifying words. We cannot guarantee future results, levels of activity, performance or achievements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or strategic alliances. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including the risks described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Factors That Could Affect Our Operating Results” and elsewhere in this quarterly report. We do not assume any obligations to update any of the forward-looking statements we make.

 

*****

 

 

3


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1.    FINANCIAL STATEMENTS

 

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS


U.S. dollars in thousands, except share and per share data

 

     March 31,
2004


   

December 31,

20031


 
     Unaudited        

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 58,615     $ 59,130  

Trade receivables, net

     10,698       10,226  

Other accounts receivable and prepaid expenses

     1,245       1,945  
    


 


Total current assets

     70,558       71,301  

Long-term investments:

                

Severance pay fund

     1,470       1,487  

Property and equipment, net

     4,595       4,792  

Goodwill

     38,398       38,398  

Other intangible assets, net

     3,232       3,455  
    


 


Total assets

   $ 118,253     $ 119,433  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Trade payables

   $ 2,124     $ 3,030  

Accrued expenses and other payables

     11,137       12,876  

Taxes payable

     859       891  

Deferred revenues

     867       1,064  
    


 


Total current liabilities

     14,987       17,861  
    


 


Accrued severance pay

     1,538       1,510  

Accrued liabilities

     1,407       1,583  
    


 


Total long-term liabilities

     2,945       3,093  
    


 


Stockholders’ equity:

                

Common Stock:

                

$0.001 par value: 100,000,000 shares authorized; 18,379,757 and 18,167,332 shares issued and outstanding at March 31, 2004 and December 31, 2003, respectively

     18       18  

Additional paid in-capital

     135,882       134,449  

Accumulated deficit

     (35,579 )     (35,988 )
    


 


Total stockholders’ equity

     100,321       98,479  
    


 


Total liabilities and stockholders’ equity

   $ 118,253     $ 119,433  
    


 



1   The December 31, 2003 balance sheet information has been derived from the December 31, 2003 audited consolidated financial statements of the Company.

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

4


Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

U.S. dollars in thousands, except per share data


 

    

Three months ended

March 31,


 
     2004

   2003

 
     Unaudited    Unaudited  

Revenues:

               

Licensing and royalties

   $ 7,769    $ 6,981  

Other revenue

     1,445      1,862  
    

  


Total revenues

     9,214      8,843  

Cost of revenues

     1,510      1,638  
    

  


Gross profit

     7,704      7,205  

Operating expenses:

               

Research and development, net

     4,009      4,049  

Sales and marketing

     1,673      1,373  

General and administrative

     1,459      1,478  

Amortization of intangible assets

     223      284  

Reorganization, restructuring and severance charge

          1,380  
    

  


Total operating expenses

     7,364      8,564  
    

  


Operating income (loss)

     340      (1,359 )

Other income (expense), net

     189      41  
    

  


Income (loss) before taxes on income

     529      (1,318 )

Taxes on income

     120       
    

  


Net income (loss)

     409      (1,318 )
    

  


Basic income (loss) per share

   $ 0.022    $ (0.073 )

Diluted income per share

   $ 0.021    $ (0.073 )

Weighted-average number of shares of Common Stock used in computation of net income (loss) per share (in thousands):

               

Basic

     18,326      18,070  

Diluted

     19,257      18,070  
    

  


 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

5


Table of Contents

INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Unaudited)

 

U.S. dollars in thousands (except share data)


 

     Common stock

    Additional
paid-in
capital


   Accumulated
deficit


    Total
stockholders’
equity


Three months ended March 31, 2004


   Shares

   Amount

        

Balance as of January 1, 2004

   18,167,332    $ 18     $ 134,449    $ (35,988 )   $ 98,479

Net income

                   409       409

Issuance of Common Stock upon exercise of stock options

   113,407      (*)     1,056            1,056

Issuance of Common Stock upon purchase of ESPP shares

   99,018      (*)     377            377
    
  


 

  


 

Balance as of March 31, 2004

   18,379,757    $ 18     $ 135,882    $ (35,579 )   $ 100,321
    
  


 

  


 


(*)   Amount less than $1.

 

     Common stock

    Additional
paid-in
capital


   Accumulated
deficit


    Total
stockholders’
equity


 

Three months ended March 31, 2003


   Shares

   Amount

        

Balance as of January 1, 2003

   18,053,507    $ 18     $ 134,051    $ (23,997 )   $ 110,072  

Net loss

                   (1,318 )     (1,318 )

Issuance of Common Stock upon exercise of stock options

   7,388      (*)     16            16  

Issuance of Common Stock upon purchase of ESPP shares

   18,224      (*)     65            65  
    
  


 

  


 


Balance as of March 31, 2003

   18,079,119    $ 18     $ 134,132    $ (25,315 )   $ 108,835  
    
  


 

  


 


 

 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

6


Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

U.S. dollars in thousands


 

    

Three months ended

March 31,


 
     2004

    2003

 
     Unaudited     Unaudited  

Cash flows from operating activities:

                

Net income (loss)

     409       (1,318 )

Adjustments required to reconcile net income (loss) to net cash used in operating activities:

                

Depreciation

     635       896  

Amortization of intangible assets

     223       284  

(Profit) loss on disposal of property and equipment

     (8 )     4  

Currency translation differences

     2       100  

Changes in operating assets and liabilities:

                

Trade receivables

     (478 )     (2,795 )

Other accounts receivable and prepaid expenses

     698       253  

Inventories

           (128 )

Trade payables

     (403 )     219  

Deferred revenues

     (197 )     (7 )

Accrued expenses and other payables

     (1,762 )     (2,741 )

Taxes payable

     (32 )     (60 )

Accrued severance pay, net

     45       (69 )
    


 


Net cash used in operating activities

     (868 )     (5,362 )
    


 


Cash flows from investing activities:

                

Purchase of property and equipment

     (947 )     (86 )

Proceeds from sale of property and equipment

     42       38  

Purchase of technology

     (30 )      
    


 


Net cash used in investing activities

     (935 )     (48 )
    


 


Cash flows from financing activities:

                

Proceeds from issuance of Common Stock upon exercise of stock options

     1,056       16  

Proceeds from issuance of Common Stock upon purchase of ESPP shares

     377       65  
    


 


Net cash provided by financing activities

     1,433       81  

Effect of exchange rate movements on cash

     (145 )     38  
    


 


Changes in cash and cash equivalents

     (515 )     (5,291 )

Cash and cash equivalents at the beginning of the period

     59,130